DENVER, Colo., and BANNOCKBURN, Ill. – Option Care CEO John Rademacher says its merger with BioScrip will create a “powerful, independent platform” in the growing $100 million infusion market.
PHOENIX – Patients with short bowel system receiving parenteral nutrition can avoid hospital readmissions when clinical interventions are provided by a nutrition support team, according to a new study from Option Care.
DENVER – BioScrip and Option Care Enterprises, two of the largest independent providers of home infusion therapy services, have entered into a definitive merger agreement, the companies announced on March 15.
DENVER – BioScrip and Option Care Enterprises, two of the largest independent providers of home infusion therapy services, have entered into a definitive merger agreement, the companies announced on March 15.
INDIANAPOLIS – Rehab Medical has acquired OMS Rehab, a Kansas City, Mo.-based provider of orthotic devices and advanced rehabilitation equipment to long-term care facilities.
Bannockburn, Ill.-based Option Care has been chosen by Paratek Pharmaceuticals as a limited network provider of its new IV and oral antibiotic Nuzyra, to treat adults with community-acquired pneumonia and acute bacterial skin infections.
NEW ORLEANS – Option Care has opened its first care management center in Louisiana, the home infusion provider announced Aug. 7. The center opened June 11 in Elmwood.
